About
Thomas is a Principal Associate in our Global M&A and Capital practice.
He advises both national and international companies on all aspects of corporate law, in particular on questions of stock corporation law, corporate reorganisations and general meetings, as well as on M&A transactions.
He speaks German and English.
Additional Information
- UniCredit on the public takeover offer for Commerzbank
- Zentiva on the public purchase offer for Apontis Pharma and the subsequent merger squeeze-out of minority shareholders
- BASF on the merger of Wintershall Dea and Harbour Energy
- Uniper on capital reduction in the amount of EUR 13.7 billion under the German Energy Security Act
- SCHOTT Pharma on IPO
- ProCredit Holding on its change of legal form into a stock corporation (Aktiengesellschaft)
- Nordex on a capital increase without subscription rights to convert shareholder loans (debt-to-equity swap)
- DZ BANK on the merger of DVB Bank into DZ BANK
- BorgWarner on the public takeover offer for AKASOL and the subsequent merger squeeze-out of minority shareholders
- Amadeus IT Group on the merger squeeze-out of the minority shareholders of i:FAO
Dr. Thomas Kelm
Principal Associate
Frankfurt am Main Office
Große Gallusstraße 14
Frankfurt am Main 60315